Objectives. To assess the outcome of arterial allografts in patients receiving organ transplantation. Design. From October 1997 to June 2005, we used fresh arterial allografts as vascular conduits in 21 patients for the treatment of claudications (10), abdominal aortic aneurysm (6), complicated renal transplantation (2), acute lower extremity ischemia (2) and gangrene (1). At the time of the vascular procedure, ten of the patients (Group A) had already undergone organ transplantation. The mean follow up period was 32 months for renal and 37 months for heart recipients, respectively. In 11 patients (Group B), the vascular reconstruction was undertaken simultaneously with the renal transplantation. The mean follow up period was 49 months.
Introduction
Progress in transplant medicine during the last 15 years has led to an expanded range of eligibility criteria for patients with an end stage organ failure selected for an organ transplant. Potential recipients of transplanted organs are increasingly older, with higher number of comorbidities. Many of these patients have peripheral arterial disease or abdominal aortic aneurysm. Furthermore, progress in transplant medicine has led to high long-term survival rates of organ recipients. In many of these patients, chronic immunosuppressive therapy accelerates the process of arteriosclerosis resulting in more marked manifestation of abdominal aortic aneurysms and peripheral arterial diseases. Prosthetic vascular grafts are not the most suitable material for vascular reconstructions in this group of patients, because of their higher susceptibility to infection.
Fresh arterial allografts were the first conduits used for reconstructions in vascular patients, as there were not that many other options at that time. 1 They were soon abandoned by surgeons because of their unsatisfactory long-term patency rates and, particularly, as prosthetic grafts became available. 2 The main reason for early arterial allograft occlusions was the patient's immune system response to alloantigens, followed by graft rupture or thrombosis. No immunosuppressive therapy was used during that early period of vascular surgery. The interest in arterial allografts was renewed when they were found to offer good solutions in the treatment of prosthetic graft infections. 3e5 The combination of physiological properties of fresh arterial allografts and higher risk of infection in the field of chronic immunosuppression suggests that these grafts should preferably be used as vascular conduits in transplanted patients. The present report summarizes our experience with the use of fresh arterial allografts in the treatment of abdominal aortic aneurysm (AAA) and peripheral arterial disease in patients with previously or simultaneously transplanted organs.
Material and Methods
The study was approved by our local ethical committee.
Patient population
From October 1997 to June 2005, we used fresh arterial allografts as vascular conduits in 21 patients. At the time of the vascular procedure, ten patients, comprising 6 females and 4 males (Group A), the mean age of whom was 59.4 years (range 50 to 67 years) had already undergone organ transplantation. The function of all transplanted organs (kidney e 3 patients, kidney þ pancreas e 1 patient, heart e 6 patients) was normal at the time of the vascular operation. The mean time elapsed between the organ and the arterial transplantations was 43 months (range 1 week to 108 months) in patients with renal transplants and 49 months (range 14 to 99 months) in patients with heart transplants, respectively. The mean follow up period was 32 months (range 17 to 51 months) in renal and 37 months (range 8 to 53 months) in heart recipients, respectively.
In 11 patients, comprising 6 males and 5 females (Group B), the mean age of whom was 52 years (range 32 to 66 years), the vascular reconstruction was undertaken simultaneously with the renal transplantation. The mean follow up period was 49 months (range 1 to 92 months). Two patients in this group had a previous history of unsuccessful renal transplantation with consecutive graftectomy (13 and 11 years ago, 9 years ago).
Indications for vascular surgery in the group of previously transplanted patients included claudications (6 cases), acute thrombosis of the popliteal artery (1 case), acute lower extremity ischemia (1 case), gangrene of the lower extremity (1 case), and symptomatic mycotic abdominal aneurysm (1 case). The types of vascular reconstructions used in this group of patients are summarized in Table 1 .
Indications for vascular surgery in the group of patients with simultaneous renal transplantation included asymptomatic abdominal aneurysm (5 cases), claudications (4 cases) and vascular complications of kidney transplantation (2 cases). The types of vascular reconstructions and indications for the simultaneous renal transplantations are summarized in Table 2 . An iliofemoral bypass during kidney re-transplantation because of a previously diagnosed asymptomatic illiac occlusion was performed on one young female patient with a history of 2 previous unsuccessful renal transplantations and consecutive graftectomies. The artery of the renal graft was anastomosed to an arterial graft. In another case, the patient with a history of an unsuccessful renal transplantation developed an acute intimal dissection of iliac artery during renal re-transplantation This case was treated by iliac artery resection and substitution by an iliofemoral graft. The renal graft artery was anastomosed to the arterial graft.
Harvest and preservation of arterial grafts
All arterial grafts were obtained from donors with the diagnosis of cerebral death in the course of a multiorgan harvest. The mean age of the donors (5 males, 5 females) in the group of previously transplanted patients was 31.5 years (range 20 to 45 years). The mean age of donors (11 males) in the group of patients with the simultaneous arterial and renal transplantations was 30.5 years (range 15 to 44 years). Renal and arterial grafts obtained from one donor were both used in a single recipient.
After removal, the arterial grafts were flushed with heparinised conservation solutions commonly used in multiorgan harvests: custodiol (n ¼ 11), UW (n ¼ 6), EuroCollins (n ¼ 3) and Soltran (n ¼ 1). The grafts were stored at a temperature of about 4 degrees Centigrade using the same types of solutions as those used for flushing, with no additional antibiotics. The mean cold ischemic time of arterial grafts was 15.6 hours (range 5 to 21 hours) in the group of patients with the previous organ transplantation. The mean cold ischemic time in the group of patients with simultaneous renal transplantation was 11.2 hours (range 5 to 24 hours) for arterial and 13 hours (range 7 to 26) for renal grafts, respectively.
The types of arterial allografts obtained by the multiorgan harvest and used as conduits for vascular reconstructions in both groups of patients are summarized in Table 3 .
Immunosuppressive therapy
All patients with a history of a previous organ transplantation were chronically immunosuppressed at the time of the arterial allograft reconstruction. Immunosuppressive protocols and blood levels of immunosuppressant drugs depended on the type of the transplanted organ and the period elapsed between the previous organ transplantation and the vascular reconstruction. The immunosuppressive regimens in patients with the renal and arterial transplantations conducted simultaneously did not differ from those used after a simple renal transplantation at our department. The type of immunosupressive regimens and mean levels of cyclosporine or tacrolimus 6, 12 and 24 months after the arterial allograft reconstructions are summarized in Tables 4, 5 and 6. In one patient, whose external iliac artery was resected and substituted by an iliofemoral graft simultaneously with the renal transplantation, primary renal allograft dysfunction developed and acute graftectomy was necessary. The immunosupressive regimen was restricted to monotherapy consisting of administering cyclosporine A for one year. The mean blood level of cyclosporine was 104.3 ng/ml. In one patient, renal transplant failure occurred 62 months from the simultaneous aortobifemoral bypass and renal transplantation. A second renal transplantation was performed 9 months later. The patient received cyclosporine A only, the mean level of which was 74.2 ng/ml, during this period.
The patients who have undergone an organ transplantation and arterial allograft reconstructions are carefully monitored by vascular surgeons, nephrologists and cardiologists during the follow up period. The patency of the reconstructions is verified by clinical examinations, ultrasonography and/or angiography (conventional or computed), periodically (Fig. 1) . The function of the transplanted organs (heart, kidney, pancreas) and levels of immunosupresive drugs are monitored in accordance with our Institute's standard policy stipulating the level of care to be extended to organ recipients.
Results
There was no death after arterial allograft reconstructions in the group of previously transplanted patients during the perioperative and early postoperative period. Four patients (40%) died during the follow up period. Three of them (2 heart recipients, 1 kidney recipient) died of a carcinoma at a different anatomical location 37, 26 and 8 months after the arterial allograft reconstruction and 37, 40 and 108 months after the organ transplantation, respectively. One heart recipient died a sudden death 53 months after the arterial allograft reconstruction and 67 months after heart transplantation, respectively. There was no arterial allograft related death in the group of previously transplanted patients.
One patient (9%) in Group B died of a GIT hemorrhage during the early postoperative period. Two patients (18.2%) died 32 and 27 months after the arterial allograft reconstruction and the renal transplantation of a GIT hemorrhage and an intracerebral hemorrhage, respectively. There were no arterial allograft related deaths in the group of previously transplanted patients.
There was only one early surgical complication in Group A. One renal recipient suffered from persistent lower extremity ischaemia, despite an acute alloarterial iliobiprofundal bypass (bifurcated graft with CyA e cyclosporine A, Aza e azathioprime, MMF e mycophenol mofetil. proximal anastomosis on the left common iliac artery), one week after a kidney transplantation. An acute fresh arterial graft e posterior tibial artery bypass with a fresh venous allograft was performed successfully five days after the first vascular intervention. The patient did not have an amputation during the follow up period. The patient died 37 months after the operation of a carcinoma, as described previously. In the other renal recipient, a crural and later femoral amputation was necessary because of an impairment of ischaemic lesion 4 months after a patent arterial ilioprofundal cross-over bypass.
No signs of fresh arterial allograft infection, stenosis or dilatation of implanted allografts, and no increased risk for previously transplanted kidney grafts has been proven in this group of patients. One renal graft failed as a result of hypovolemic shock of the patient bleeding from a urinary bladder carcinoma 37 months after the renal transplantation and subsequent iliobiprofundal bypass.
In Group B, a higher incidence of early surgical complications was observed. Acute lower extremity ischemia developed in one patient after an aortofemoral bypass and simultaneous patch angioplasty of the contralateral deep femoral artery. Ten days after the first intervention, an acute prosthetic proximal femoropopliteal bypass was performed with good results. A complete wound dehiscence treated by re-suturing occurred in another patient after an intraperitoneal renal transplantation and simultaneous AAA resection and substitution with thoracic aorta during the early postoperative period. Ischemic colitis and perforation of the colon developed in another patient after a simultaneous AAA repair and renal transplantation in the early postoperative period. The inferior mesenteric artery was ligated during the AAA resection. Reoperation and subtotal colectomy was undertaken. Subsequently, acute renal failure with a short-term need for dialysis developed. Corticoresistant acute rejection was diagnosed and successfuly treated. No signs of arterial allograft infection were noticed in this patient during the subsequent follow up period.
In Group B, no signs of fresh arterial allograft infection, stenosis or dilatation of implanted allografts have been demonstrated. Ureteral stenosis of the transplanted kidney was observed in two renal recipients in the first 6 months after the operation. They were successfully treated by short-term percutaneous drainage nephrostomy. One primary renal allograft dysfunction with consequent graftectomy and one chronic renal failure 62 months from the surgery, was noticed in the group of simultaneously transplanted patients.
Discussion
Advancements in transplant medicine, which are attributable mainly to the development of new potent immunosupressive drugs, have led to an expanded range of eligibility criteria in selecting patients with end stage organ failure for an organ transplant, and improved posttransplantation survival rates. The number of potential recipients of organs with co-morbities, including serious forms of atherosclerosis, peripheral arterial disease, abdominal aortic aneurysms and diabetes mellitus is growing. Severe arteriosclerosis and/ or peripheral arterial occlusive disease results in difficult arterial anastomosis and intraoperative arterial injuries during kidney and/or pancreas transplantations. 6 The number of reports describing the developement of abdominal aortic aneurysm (AAA) after renal, 7 cardiac, 8 pulmonary 9 or liver 10 transplantation is growing. 11 The choice of conduit for vascular reconstructions in patients receiving chronic immunosuppression is controversial. The use of prosthetic prostheses is limited by the risk of infection. The interruption of immunosuppressive drugs might result in a failure of the transplanted organ, despite the successful treatment of the prosthetic graft infection. The risk of infectious complications is higher, especially if a two-stage procedure is used, i.e. when the organ transplantation follows after the vascular reconstruction. 12 Since 1950, backed by experimental studies, 13 fresh arterial allografts were used as the initial material for vascular reconstructions in humans. 1, 14, 15 Their use, however, was soon abandoned because of late degenerative changes in grafts 2 and a number of previously transplanted allografts were removed and replaced with Dacron grafts. 2 The immunogenicity of the arterial wall was considered to be the main reason for the degenerative changes of allografts. The immune response against antigens in the arterial wall has been confirmed in animals 16e19 as well as in humans 20, 21 in the last 20 years. Allograft rejection is prevented by calcineurin inhibitors, such as cyclosporine A and tacrolimus. 16,22e24 Arterial allografts re-appeared in clinical practice in the 1980s and 1990s. At that time, vascular surgeons had to cope with infections of prosthetic grafts. 3e5,25e27 A good resistance of arterial allografts to infection was the main reason why they have been used to treat vascular prosthesis infections with good results. 28e31 All the data about the abovementioned properties of arterial allografts prompted their use in chronically immunosuppressed transplanted patients. In 1994 Dinis da Gama 32 reported 16 ABO-compatible cryopreserved arterial allografts being transplanted into thirteen patients with a transplanted kidney who received azathioprine, cyclosporine and prednisone. No signs of cellular mediated rejection were noted in this study.
The lower immunogenicity of cryopreserved, compared to fresh allografts is controversial. 33e36 The most advantageous attribute of cryopreserved grafts stored in tissue banks is the ability to obtain suitable grafts whenever needed. At our Institute, the Vascular Unit is integrated into the Transplant Centre, so this handicap can be minimized or even completely eliminated (in the case of simultaneous renal and arterial transplantations, when both grafts are obtained from the same donor). We use so called fresh arterial allografts e arteries obtained in a multiorgan harvest and stored in a preservation solution at 4 C for a maximum of 36 hours e for two main indications. They are used as conduits for reconstructive surgery in the treatment of an intercurrent obstructive or aneurysmal vascular disease in previously as well as in simultaneously transplanted patients.
The most frequent intercurrent vascular diagnosis of renal recipients in Group B was asymptomatic abdominal aortic aneurysm. There are two treatment options to choose from in such circumstances e an endovascular graft implantation, or an AAA resection and substitution.
We utilize open surgery when there are contraindications to endovascular stents. The most frequently recommended tactic is a two-stage procedure. The first step is the abdominal aortic aneurysm resection and substitution with a vascular prosthesis. The renal transplantation follows later. The recommended interval between the vascular reconstruction and the subsequent renal transplantation is 6 weeks to 3 months. 37, 38 A simultaneous AAA resection and substitution combined with a renal transplantation is an alternative approach in such cases. The first case of a patient treated in this way was described by Cerilli et al. in 1977. 39 The most notable advantage of the single-stage procedure is the necessity for only one admission, anesthetic and operation. The cost benefit of the one-step approach is not negligible as well. An artificial vascular prosthesis or a fresh arterial allograft are available as conduits for vascular reconstructions. The benefit of the one-stage procedure used on a patient with an AAA combined with a renal and liver failure has been previously documented. 10 The combined arterial allograft reconstructions and kidney transplantation is performed on an urgent basis and before the results of HLA donor's and recipient's antigen match testing are available. The risk of delayed function of the renal graft is increased only in the event of intraoperative complications. 40 Arterial allografts are also used in pancreas and renal transplantation when required. 6, 32, 41 Two patients with a history of a renal transplantation and graftectomy were earmarked for renal re-transplantations in our group. In both of them, iliofemoral allografts were transplanted simultaneously because of the recipient's iliac artery occlussion and acute intimal dissection, respectively. The renal grafts arteries were anastomosed to the arterial grafts.
A patient with a transplanted organ, who is undergoing immunosuppressive therapy, is an ideal recipient for arterial allografts, if arterial reconstructive surgery is required. On the basis of our experience, is it possible to use fresh arterial allografts in the treatment of arterial occlusive disease or AAA, both for patients who have already undergone transplantation and simultaneously with the organ transplantation, with good results.
